Artivion (AORT) EBIT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294.00 |
| Dec 31, 2025 | 639.00 |
| Sep 30, 2025 | 548.00 |
| Jun 30, 2025 | 1,099.00 |
| Mar 31, 2025 | 395.00 |
| Dec 31, 2024 | 2,149.00 |
| Sep 30, 2024 | -235.00 |
| Jun 30, 2024 | -250.00 |
| Mar 31, 2024 | 2,271.00 |
| Dec 31, 2023 | 1,500.00 |
| Sep 30, 2023 | -856.00 |
| Jun 30, 2023 | 71.00 |
| Mar 31, 2023 | 99.00 |
| Dec 31, 2022 | 557.00 |
| Sep 30, 2022 | -723.00 |
| Jun 30, 2022 | -436.00 |
| Mar 31, 2022 | -354.00 |
| Dec 31, 2021 | 1,105.00 |
| Sep 30, 2021 | 824.00 |
| Jun 30, 2021 | -800.00 |
| Mar 31, 2021 | -1,343.00 |
| Dec 31, 2020 | -932.00 |
| Sep 30, 2020 | -131.00 |
| Jun 30, 2020 | -228.00 |
| Mar 31, 2020 | 281.00 |
| Dec 31, 2019 | -2,387.00 |
| Sep 30, 2019 | -120.00 |
| Jun 30, 2019 | 273.00 |
| Mar 31, 2019 | -148.00 |
| Dec 31, 2018 | -446.00 |
| Sep 30, 2018 | -544.00 |
| Jun 30, 2018 | -50.00 |
| Mar 31, 2018 | -1,495.00 |
| Dec 31, 2017 | -672.00 |
| Sep 30, 2017 | -693.00 |
| Jun 30, 2017 | -755.00 |
| Mar 31, 2017 | 61.00 |
| Dec 31, 2016 | -2,895.00 |
| Sep 30, 2016 | 529.00 |
| Jun 30, 2016 | 355.00 |
| Mar 31, 2016 | 995.00 |
| Dec 31, 2015 | 490.00 |
| Sep 30, 2015 | 1,754.00 |
| Jun 30, 2015 | -1,129.00 |